Historically viewed as a localized gastrointestinal malignancy, colorectal cancer (CRC) is increasingly recognized as a systemic pathology that actively programs distant microenvironments. This review delineates a novel mechanistic framework wherein CRC‐driven dysregulation of the brain–gut–microbiota axis (BGMA) acts as a systemic architect of the breast pre‐metastatic niche (PMN). We synthesize how localized intestinal oncogenic stress propagates through three convergent conduits: (1) Immune Reprogramming, where gut‐derived inflammatory mediators and extracellular vesicles (EVs) recruit myeloid‐derived suppressor cells (MDSCs) to the mammary stroma; (2) Neuro‐ecological Conditioning, involving chronic hypothalamic–pituitary–adrenal (HPA) axis activation and sympathetic hyperactivation that drives catecholamine‐mediated remodeling of breast tissue; and (3) Humoral‐Metabolic Convergence, specifically via the “estrobolome” and secondary bile acids that synchronize systemic hormonal levels with local tissue receptivity. By reframing CRC progression as a systemic pathology that potentially preconditions distant, hormone‐sensitive environments, we propose the BGMA as a conceptual framework for prospective “systemic interception”, outlining roadmaps to neutralize metastatic cascades at their incipient, reversible stages.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: